Health Condition 1: B342- Coronavirus infection, unspecified
Conditions
Interventions
Intervention1: Group I : (Ayurveda as add-on to standard care as per: guidelines)
AYUSH 64
Dose 2 capsules (500 mg each) thrice daily
Dosage form Capsules/Tablets
Route of Administration Oral
Tim
Sponsors
Central council for research in Ayurveda and Siddha
Eligibility
Inclusion criteria
Inclusion criteria: 1. Typical clinical presentation of acute onset febrile illness with sore throat and dry cough with or without shortness of breath and a RT_PCR based laboratory confirmation test for COVID-19 2. Patients presenting with or without Typical clinical presentation but having RT_PCR based laboratory confirmation test for COVID-19 3. Patients with either sex, 18 to 75 years age 4. Patients with mild-moderately severe disease 5. All patients must agree not to share medication 6. Patients willing to participate and sign an informed consent Understands and agrees to comply with planned study procedures. 7. Agrees to the give OP swabs and venous blood for testing as per protocol
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| a) Mean time (days) for clinical recovery [Day of randomization to the day of clinical recovery (see criteria below)] b) Proportion of patients showing â??clinical recoveryâ?? Timepoint: 7-15-30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Percentage of patients with negative SARS-CoV-2 on nasal or throat swab in a 2-day continuous real time RT-PCR test 3. Proportion of patients developing an event that reflects clinical or otherwise improvement of worsening 5. Improvement in selected laboratory parametersTimepoint: 7-15-30 days | — |
Countries
India
Contacts
Public ContactDr Nataraj H R
Shri Dharmasthala manjunatheshwara college of Ayurveda Hassan
Outcome results
None listed